Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial-Reference-Cited by-同舟云学术

Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial

Published:2022-01-15 Issue:2 Volume:40 Page:349-360
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Zhou Daobin,Xu Wei,Ma Hongbing,Zhao Chunting,Hu Yu,Zhao Yaozhong,Wu Depei,Zhao Xielan,He Yanjuan,Yan Jinsong,Wang Chunsen,Meng Fanyi,Jin Jie,Zhang Xiaohong,Yu Kang,Hu Jianda,Lv Yue

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10637-021-01206-2.pdf

Reference38 articles.

1. Al-Sawaf O, Zhang C, Robrecht S, Fink A-M, Cramer P, Herling CD, Von Tresckow J, Lange E, Böttcher S, Kiehl MG et al (2020) Severe Infections in Patients with Chronic Lymphocytic Leukemia Treated with (Immuno-)Chemotherapy: A Pooled Analysis of Gcllsg Trials. Blood 136:18–19. https://doi.org/10.1182/blood-2020-139242

2. Bergmann MA, Goebeler ME, Herold M, Emmerich B, Wilhelm M, Ruelfs C, Boening L, Hallek MJ, German CLLSG (2005) Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I/II study of the German CLL Study Group. Haematologica 90:1357–1364. https://doi.org/10.3324/%25x

3. Bogeljić Patekar M, Milunović V, Mišura Jakobac K, Perica D, Mandac Rogulj I, Kursar M, Planinc-Peraica A, Ostojić Kolonić S (2018) Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia. Acta Clin Croat 57:542–553. https://doi.org/10.20471/acc.2018.57.03.18

4. Burger JA (2020) Treatment of Chronic Lymphocytic Leukemia. N Engl J Med 383:460–473. https://doi.org/10.1056/NEJMra1908213

5. Burger JA, O’Brien S (2018) Evolution of CLL treatment - from chemoimmunotherapy to targeted and individualized therapy. Nat Rev Clin Oncol 15:510–527. https://doi.org/10.1038/s41571-018-0037-8

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in the impact of human microbiota and probiotics on leukemia;Frontiers in Microbiology;2024-07-03

2. Preparation, characterization and biochemical studies of nanoformulations of chlorambucil to enhance anticancer efficacy;New Journal of Chemistry;2023